再髓鞘化
小胶质细胞
多发性硬化
髓鞘
神经科学
生物
少突胶质细胞
祖细胞
细胞生物学
免疫学
中枢神经系统
干细胞
炎症
作者
Charbel S. Baaklini,Madelene F. S. Ho,Tristan Lange,Brady P. Hammond,Sharmistha P. Panda,Martin Zirngibl,Sameera Zia,Kassandre Himmelsbach,Heli Rana,Braxton Phillips,Daria Antoszko,Jeremies Ibanga,M.F. Molina López,Kelly V. Lee,Michael B. Keough,Andrew V. Caprariello,Bradley J. Kerr,Jason R. Plemel
出处
期刊:Cell Reports
[Cell Press]
日期:2023-12-01
卷期号:42 (12): 113574-113574
被引量:7
标识
DOI:10.1016/j.celrep.2023.113574
摘要
Multiple sclerosis (MS) is an inflammatory disease characterized by myelin loss. While therapies exist to slow MS progression, no treatment currently exists for remyelination. Remyelination, linked to reduced disability in MS, relies on microglia and monocyte-derived macrophages (MDMs). This study aims to understand the role of microglia during remyelination by lineage tracing and depleting them. Microglial lineage tracing reveals that both microglia and MDMs initially accumulate, but microglia later dominate the lesion. Microglia and MDMs engulf equal amounts of inhibitory myelin debris, but after microglial depletion, MDMs compensate by engulfing more myelin debris. Microglial depletion does, however, reduce the recruitment and proliferation of oligodendrocyte progenitor cells (OPCs) and impairs their subsequent differentiation and remyelination. These findings underscore the essential role of microglia during remyelination and offer insights for enhancing this process by understanding microglial regulation of remyelination.
科研通智能强力驱动
Strongly Powered by AbleSci AI